{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:53:50Z","timestamp":1754160830684,"version":"3.41.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,27]]},"DOI":"10.7759\/cureus.88860","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T23:08:26Z","timestamp":1753657706000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Renal Failure Due to Amyloidosis Associated With Intravenous Heroin Use"],"prefix":"10.7759","author":[{"given":"Ramya","family":"Malchira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghu","family":"Konanur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"AA protein-related renal amyloidosis in drug addicts","volume":"112","author":"Menchel S","year":"1983","unstructured":"Menchel S, Cohen D, Gross E, Frangione B, Gallo G. AA protein-related renal amyloidosis in drug addicts. Am J Pathol. 1983, 112:195-9.","journal-title":"Am J Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2022.100360","article-title":"Drugs of abuse and kidney toxicity","volume":"32","author":"Silva JP","year":"2022","unstructured":"Silva JP, Carmo H, Carvalho F. Drugs of abuse and kidney toxicity. Curr Opin Toxicol. 2022, 32:100360. 10.1016\/j.cotox.2022.100360","journal-title":"Curr Opin Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, amyloidosis","volume":"44","author":"Papa R","year":"2018","unstructured":"Papa R, Lachmann HJ. Secondary, AA, amyloidosis. Rheum Dis Clin North Am. 2018, 44:585-603. 10.1016\/j.rdc.2018.06.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.631299","article-title":"Serum amyloid A in inflammatory rheumatic diseases: a compendious review of a renowned biomarker","volume":"11","author":"Sori\u0107 Hosman I","year":"2021","unstructured":"Sori\u0107 Hosman I, Kos I, Lamot L. Serum amyloid A in inflammatory rheumatic diseases: a compendious review of a renowned biomarker. Front Immunol. 2021, 11:631299. 10.3389\/fimmu.2020.631299","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2018.11.013","article-title":"Secondary amyloidosis associated with heroin use and recurrent infections - a case report","volume":"22","author":"Mani D","year":"2018","unstructured":"Mani D. Secondary amyloidosis associated with heroin use and recurrent infections - a case report. Ann Med Surg (Lond). 2018, 22:38-41. 10.1016\/j.amsu.2018.11.013","journal-title":"Ann Med Surg (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12860\/JNP.2013.31","article-title":"Serum amyloid A renal amyloidosis in a chronic subcutaneous (\u201cskin popping\u201d) heroin user","volume":"2","author":"Cooper C","year":"2013","unstructured":"Cooper C, Bilbao JE, Said S, et al.. Serum amyloid A renal amyloidosis in a chronic subcutaneous (\u201cskin popping\u201d) heroin user. J Nephropathol. 2013, 2:196-200. 10.12860\/JNP.2013.31","journal-title":"J Nephropathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.01.530","article-title":"2024 update on classification, etiology, and typing of renal amyloidosis: a review","volume":"84","author":"Leung N","year":"2024","unstructured":"Leung N, Nasr SH. 2024 update on classification, etiology, and typing of renal amyloidosis: a review. Am J Kidney Dis. 2024, 84:361-73. 10.1053\/j.ajkd.2024.01.530","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"Buxbaum JN","year":"2022","unstructured":"Buxbaum JN, Dispenzieri A, Eisenberg DS, et al.. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2022, 29:213-9. 10.1080\/13506129.2022.2147636","journal-title":"Amyloid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1039\/c9cs00199a","article-title":"Half a century of amyloids: past, present and future","volume":"49","author":"Ke PC","year":"2020","unstructured":"Ke PC, Zhou R, Serpell LC, et al.. Half a century of amyloids: past, present and future. Chem Soc Rev. 2020, 49:5473-509. 10.1039\/c9cs00199a","journal-title":"Chem Soc Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2123558","article-title":"Systematic review of accuracy of reporting of Congo red-stained amyloid in 2010-2020 compared with earlier","volume":"54","author":"Howie AJ","year":"2022","unstructured":"Howie AJ, Owen-Casey MP. Systematic review of accuracy of reporting of Congo red-stained amyloid in 2010-2020 compared with earlier. Ann Med. 2022, 54:2511-6. 10.1080\/07853890.2022.2123558","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13295","article-title":"The turning away of serum amyloid A biological activities and receptor usage","volume":"163","author":"Abouelasrar Salama S","year":"2021","unstructured":"Abouelasrar Salama S, Gouwy M, Van Damme J, Struyf S. The turning away of serum amyloid A biological activities and receptor usage. Immunology. 2021, 163:115-27. 10.1111\/imm.13295","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann HJ","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007, 356:2361-71. 10.1056\/NEJMoa070265","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore JD","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001, 358:24-9. 10.1016\/S0140-6736(00)05252-1","journal-title":"Lancet"},{"key":"ref14","article-title":"Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013","volume":"64","author":"Jones CM","year":"2015","unstructured":"Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015, 64:719-25.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13641217","article-title":"Heroin use is associated with AA-type kidney amyloidosis in the Pacific Northwest","volume":"13","author":"Sharma A","year":"2018","unstructured":"Sharma A, Govindan P, Toukatly M, et al.. Heroin use is associated with AA-type kidney amyloidosis in the Pacific Northwest. Clin J Am Soc Nephrol. 2018, 13:1030-6. 10.2215\/CJN.13641217","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381996-acute-renal-failure-due-to-amyloidosis-associated-with-intravenous-heroin-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T23:08:32Z","timestamp":1753657712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381996-acute-renal-failure-due-to-amyloidosis-associated-with-intravenous-heroin-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.88860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,27]]}}}